[1. Ott JJ, Ullrich A, Mascarenhas M, Stevens GA. Global cancer incidence and mortality caused by behavior and infection. J Public Health (Oxf). 2011;33(2):223-33. DOI: 10.1093/pubmed/fdq07610.1093/pubmed/fdq076]Open DOISearch in Google Scholar
[2. Chen BF. Hepatitis B virus pre-S/S variants in liver diseases. World J Gastroenterol. 2018;24(14):1507-20. DOI: 10.3748/wjg.v24.i14.150710.3748/wjg.v24.i14.1507]Open DOISearch in Google Scholar
[3. Lavanchy D, Kane M. Global Epidemiology of Hepatitis B Virus Infection. Hepatitis B Virus in Human Diseases.Springer; 2016. p. 187-203. DOI: 10.1007/978-3-319-22330-8_910.1007/978-3-319-22330-8_9]Open DOISearch in Google Scholar
[4. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020-6. DOI: 10.1016/j.cmi.2015.06.02810.1016/j.cmi.2015.06.028]Open DOISearch in Google Scholar
[5. Whalley SA, Murray JM, Brown D, Webster GJ, Emery VC, Dusheiko GM, et al. Kinetics of acute hepatitis B virus infection in humans. J Exp Med. 2001;193(7):847-54. DOI: 10.1084/jem.193.7.84710.1084/jem.193.7.847]Open DOISearch in Google Scholar
[6. Coppola N, Onorato L, Minichini C, Di Caprio G, Starace M, Sagnelli C, et al. Clinical significance of hepatitis B surface antigen mutants. World J Hepatol. 2015;7(27):2729-39. DOI: 10.4254/wjh.v7.i27.272910.4254/wjh.v7.i27.2729]Open DOISearch in Google Scholar
[7. Pondé R. Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis. Eur J Clin Microbiol Infect Dis. 2016;35(1):29-40. DOI: 10.1007/s10096-015-2522-710.1007/s10096-015-2522-7]Open DOISearch in Google Scholar
[8. Teo CG, Locarnini SA. Potential threat of drug-resistant and vaccine-escape HBV mutants to public health. Antivir Ther. 2010;15(3 Pt B):445-9. DOI: 10.3851/IMP155610.3851/IMP1556]Open DOISearch in Google Scholar
[9. Sticchi L, Caligiuri P, Cacciani R, Alicino C, Bruzzone B. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. Hum Vaccin Immunother. 2013;9(3):568-71. DOI: 10.4161/hv.2323610.4161/hv.23236]Open DOISearch in Google Scholar
[10. Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pour-dast A, Alavian SM, et al. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon. 2016;16(7):e39097. DOI: 10.5812/hepatmon.3909710.5812/hepatmon.39097]Search in Google Scholar
[11. Sayan M, Bugdaci MS. [HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues]. Mikrobiyol Bul. 2013;47(3):544-9. DOI: 10.5578/mb.544210.5578/mb.5442]Open DOISearch in Google Scholar
[12. Hosseini SY, Sanaei N, Fattahi MR, Malek-Hosseini SA, Sarvari J. Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients. Ann Hepatol. 2019;18(4):640-5. DOI: 10.1016/j.aohep.2018.12.00610.1016/j.aohep.2018.12.006]Open DOISearch in Google Scholar
[13. Özgüler M, Sayan M. Could resistant and escape variants of hepatitis B virus be a problem in the future? Future Virol. 2018;13(3):171-9. DOI: 10.2217/fvl-2017-014410.2217/fvl-2017-0144]Open DOISearch in Google Scholar
[14. Gencay M, Seffner A, Pabinger S, Gautier J, Gohl P, Weizenegger M, et al. Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays. J Viral Hepat. 2018;25(10):1132-8. DOI: 10.1111/jvh.1291510.1111/jvh.12915]Search in Google Scholar
[15. Gencay M, Vermeulen M, Neofytos D, Westergaard G, Pabinger S, Kriegner A, et al. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: reliable detection of HBV by the Elecsys HBsAg II assay. J Clin Virol. 2018;101:38-43. DOI: 10.1016/j.jcv.2018.01.01110.1016/j.jcv.2018.01.011]Open DOISearch in Google Scholar
[16. Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S. Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples. J Clin Virol. 2017;89:14-21. DOI: 10.1016/j.jcv.2017.02.00110.1016/j.jcv.2017.02.001]Open DOISearch in Google Scholar
[17. Hsu H-Y, Chang M-H, Ni Y-H, Chiang C-L, Chen H-L, Wu J-F, et al. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis. 2010;201(8):1192-200. DOI: 10.1086/65137810.1086/651378]Search in Google Scholar
[18. Purdy MA. Hepatitis B virus S gene escape mutants. Asian J Transfus Sci. 2007;1(2):62-70. DOI: 10.4103/0973-6247.3344510.4103/0973-6247.33445]Open DOISearch in Google Scholar
[19. Oon CJ, Chen WN. Current aspects of hepatitis B surface antigen mutants in Singapore. J Viral Hepat. 1998;5 Suppl 2:17-23. DOI: 10.1046/j.1365-2893.1998.0050s2017.x10.1046/j.1365-2893.1998.0050s2017.x]Open DOISearch in Google Scholar
[20. Pondé RA. Atypical serological profiles in hepatitis B virus infection. Eur J Clin Microbiol Infect Dis. 2013;32(4):461-76. DOI: 10.1007/s10096-012-1781-910.1007/s10096-012-1781-9]Open DOISearch in Google Scholar